UNITY BIOTECHNOLOGY INC. - Daily - Technical analysis published on 09/12/2019 (GMT)
- 304
- 0
- Who voted?
I am delighted to see that my first price objective has been achieved. I hope you've taken advantage of it.
Click here for a new analysis!
Click here for a new analysis!
- Timeframe : Daily
- - Analysis generated on
- Status : TARGET REACHED
Summary of the analysis
Trends
Court terme:
Strongly bullish
De fond:
Slightly bearish
Technical indicators
89%
0%
11%
My opinion
Bullish above 6.67 USD
My targets
8.02 USD (+2.30%)
10.24 USD (+30.61%)
My analysis
The strong short-term increase in UNITY BIOTECHNOLOGY INC. calls into question the currently slightly bearish basic trend. A trend reversal is likely. As long as the price remains above 6.67 USD, you could consider taking advantage of the short-term movement. The first bullish objective is located at 8.02 USD. The bullish momentum would be boosted by a break in this resistance. Buyers would then use the next resistance located at 10.24 USD as an objective. Crossing it would then enable buyers to target 11.77 USD. Caution, a return under 6.67 USD could jeopardize the reversal.
In the very short term, technical indicators confirm the bullish opinion of this analysis. It is appropriate to continue watching any excessive bullish movements or scanner detections which might lead to a small bearish correction.
FORCE
0
10
3.2
Warning: This content is for information purposes only and in no way constitutes investment advice or any incentive whatsoever to buy or sell financial instruments. All elements of the analysis are of a "general" nature and are based on market conditions at a given time. CentralCharts is not responsible for any incorrect or incomplete information. Every investor must judge for themselves before investing in a financial instrument so as to adapt it to their financial, tax and legal situation. CentralCharts shall not, under any circumstances, be liable for any loss or lower income incurred as a result of reading this content. Trading in financial instruments is random and any investment may expose you to risks of loss greater than deposits and is only suitable for sophisticated investors with the financial means to bear such risk.
This analysis was given by Vincent Launay. Take part yourself by sharing additional analysis on another time unit:
Additional analysis
Quotes
UNITY BIOTECHNOLOGY INC. rating 7.84 USD. The price has increased by +3.29% since the last closing and was between 7.62 USD and 8.10 USD. This implies that the price is at +2.89% from its lowest and at -3.21% from its highest.7.62
8.10
7.84
The Central Gaps scanner detects a bullish opening. A small advantage for buyers in the very short term.
Bullish opening
Type : Bullish
Timeframe : Openning
Here is a more detailed summary of the historical variations registered by UNITY BIOTECHNOLOGY INC.:
Technical
A technical analysis in Daily of this UNITY BIOTECHNOLOGY INC. chart shows a slightly bearish trend. Only 57.14% of the signals given by moving averages are bearish. This slightly bearish trend could quickly be reversed due to the strong bullish signals currently being given by short-term moving averages. The Central Indicators scanner does not detect any result on moving averages that would impact this trend.
In fact, according to the parameters integrated into the Central Analyzer system, 16 technical indicators out of 18 analysed are currently bullish. Caution: the Central Indicators scanner currently detects an excess:
CCI indicator is overbought : over 100
Type : Neutral
Timeframe : Daily
Previous candle closed over Bollinger bands
Type : Neutral
Timeframe : Daily
Williams %R indicator is overbought : over -20
Type : Neutral
Timeframe : Daily
Pivot points : price is over resistance 2
Type : Neutral
Timeframe : Weekly
Price is back over the pivot point
Type : Bullish
Timeframe : Daily
Central Patterns, the market scanner focusing on chart patterns, resistances and supports found this result:
Near resistance of channel
Type : Bearish
Timeframe : Daily
The Central Candlesticks scanner, specialised in Japanese candlesticks, did not identify any signals.
ProTrendLines
S2
S1
R1
R2
R3
Price
| S2 | S1 | Price | R1 | R2 | R3 | |
|---|---|---|---|---|---|---|
| ProTrendLines | 5.62 | 6.67 | 7.84 | 8.02 | 10.24 | 11.77 |
| Change (%) | -28.32% | -14.92% | - | +2.30% | +30.61% | +50.13% |
| Change | -2.22 | -1.17 | - | +0.18 | +2.40 | +3.93 |
| Level | Major | Minor | - | Major | Intermediate | Minor |
Pivot points can also be used to set your price objectives. Here is the price situation in relation to pivot points:
Daily
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 6.41 | 6.78 | 7.18 | 7.55 | 7.95 | 8.32 | 8.72 |
| Camarilla | 7.38 | 7.45 | 7.52 | 7.59 | 7.66 | 7.73 | 7.80 |
| Woodie | 6.43 | 6.79 | 7.21 | 7.56 | 7.98 | 8.33 | 8.75 |
| Fibonacci | 6.78 | 7.07 | 7.25 | 7.55 | 7.84 | 8.02 | 8.32 |
Weekly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 4.69 | 5.23 | 5.98 | 6.52 | 7.27 | 7.81 | 8.56 |
| Camarilla | 6.38 | 6.49 | 6.61 | 6.73 | 6.85 | 6.97 | 7.09 |
| Woodie | 4.80 | 5.28 | 6.09 | 6.57 | 7.38 | 7.86 | 8.67 |
| Fibonacci | 5.23 | 5.72 | 6.03 | 6.52 | 7.01 | 7.32 | 7.81 |
Monthly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 3.52 | 4.57 | 5.33 | 6.38 | 7.14 | 8.19 | 8.95 |
| Camarilla | 5.60 | 5.77 | 5.93 | 6.10 | 6.27 | 6.43 | 6.60 |
| Woodie | 3.39 | 4.50 | 5.20 | 6.31 | 7.01 | 8.12 | 8.82 |
| Fibonacci | 4.57 | 5.26 | 5.69 | 6.38 | 7.07 | 7.50 | 8.19 |
Numerical data
The following is the status of technical indicators and moving averages registered at the time this technical analysis was created:
Technical indicators
Moving averages
| RSI (14): | 70.10 | |
| MACD (12,26,9): | 0.0800 | |
| Directional Movement: | 19.91 | |
| AROON (14): | 64.29 | |
| DEMA (21): | 6.61 | |
| Parabolic SAR (0,02-0,02-0,2): | 6.21 | |
| Elder Ray (13): | 1.13 | |
| Super Trend (3,10): | 6.36 | |
| Zig ZAG (10): | 7.84 | |
| VORTEX (21): | 1.1000 | |
| Stochastique (14,3,5): | 87.65 | |
| TEMA (21): | 7.01 | |
| Williams %R (14): | -10.44 | |
| Chande Momentum Oscillator (20): | 1.89 | |
| Repulse (5,40,3): | 10.3900 | |
| ROCnROLL: | 1 | |
| TRIX (15,9): | -0.4600 | |
| Courbe Coppock: | 25.03 |
| MA7: | 6.84 | |
| MA20: | 6.33 | |
| MA50: | 7.08 | |
| MA100: | 7.85 | |
| MAexp7: | 7.04 | |
| MAexp20: | 6.65 | |
| MAexp50: | 7.03 | |
| MAexp100: | 7.85 | |
| Price / MA7: | +14.62% | |
| Price / MA20: | +23.85% | |
| Price / MA50: | +10.73% | |
| Price / MA100: | -0.13% | |
| Price / MAexp7: | +11.36% | |
| Price / MAexp20: | +17.89% | |
| Price / MAexp50: | +11.52% | |
| Price / MAexp100: | -0.13% |
News
The last news published on UNITY BIOTECHNOLOGY INC. at the time of the generation of this analysis was as follows:
- UNITY Biotechnology, Inc. to Participate in Upcoming Investor Conferences
- UNITY Biotechnology, Inc. Reports Second Quarter 2019 Financial Results and Program Updates
- UNITY Biotechnology, Inc. Announces Plan for Phase 2 Clinical Study of UBX0101 in Osteoarthritis of the Knee
- UNITY Biotechnology Reports Promising Topline Data from Phase 1 First-in-human Study of UBX0101 in Patients with Osteoarthritis of the Knee
- UNITY Biotechnology, Inc. and UCSF Enter Exclusive License Agreement on alpha-Klotho Protein for the Treatment of Age-Related Cognitive Decline
This member declared not having a position on this financial instrument or a related financial instrument.
About author
Online
I am Londinia, an artificial intelligence program dedicated to stock market analysis. I am able to analyse and interpret graphical and market data. Learn more…
Add a comment
Comments
0 comments on the analysis UNITY BIOTECHNOLOGY INC. - Daily